ATAI Life Sciences NV () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1289785,
    "name": "ATAI Life Sciences NV",
    "stock_name": "ATAI Life Sciences NV",
    "full_name": "ATAI Life Sciences NV",
    "name_url": "stocks-analysis/atai-life-sciences-nv",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "4.40",
    "chg": 0.53,
    "chgp": "13.7%",
    "dir": 1,
    "prev_price": "3.87",
    "mcapval": "968.81",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "NL0015000DX5",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "11.14 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/atai-life-sciences-nv-1289785-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is ATAI Life Sciences NV technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-atai-life-sciences-nv-technically-bullish-or-bearish-3617749",
        "imagepath": "",
        "date": "2025-10-14 11:40:04",
        "description": "As of 10 October 2025, the technical trend for ATAI Life Sciences NV has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is also bullish, indicating positive momentum. However, the RSI shows a bearish stance on both the weekly and monthly charts, suggesting potential weakness. The Bollinger Bands are mildly bullish on both time frames, and the daily moving averages are bullish, supporting a positive short-term outlook. The KST is bullish on both weekly and monthly charts, but Dow Theory indicates a mildly bearish trend on the weekly, with no trend on the monthly.\n\nIn terms of performance, ATAI Life Sciences has significantly outperformed the S&P 500 year-to-date with a return of 306.02% compared to the S&P 500's 11.41%. Over the past year, ATAI has returned 390.91%, while the S&P 500 returned 13.36%. Overall, the current technical stance is mildly bullish, driven b..."
      },
      {
        "title": "Is ATAI Life Sciences NV technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-atai-life-sciences-nv-technically-bullish-or-bearish-3614744",
        "imagepath": "",
        "date": "2025-10-13 11:41:55",
        "description": "As of 10 October 2025, the technical trend for ATAI Life Sciences NV has changed from bullish to mildly bullish. The current stance is mildly bullish, driven by a bullish MACD on both weekly and monthly time frames, and bullish moving averages on the daily chart. However, the weekly and monthly RSI readings are bearish, indicating some weakness. Additionally, the Bollinger Bands are mildly bullish, while the Dow Theory shows a mildly bearish signal on the weekly chart. \n\nIn terms of performance, ATAI Life Sciences has significantly outperformed the S&P 500 year-to-date with a return of 283.46% compared to the S&P 500's 11.41%, and over the past year, it has returned 372.22% versus the S&P 500's 13.36%...."
      },
      {
        "title": "Is ATAI Life Sciences NV technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-atai-life-sciences-nv-technically-bullish-or-bearish-3613074",
        "imagepath": "",
        "date": "2025-10-12 11:29:01",
        "description": "As of 10 October 2025, the technical trend for ATAI Life Sciences NV has changed from bullish to mildly bullish. The weekly MACD and KST indicators remain bullish, while the daily moving averages are also bullish. However, the weekly and monthly RSI readings are bearish, indicating some weakness. The Bollinger Bands show a mildly bullish stance on both weekly and monthly time frames. According to Dow Theory, the weekly trend is mildly bearish, but there is no trend on the monthly level. \n\nIn terms of performance, ATAI has significantly outperformed the S&P 500 year-to-date with a return of 283.46% compared to the S&P 500's 11.41%, and over the past year, it has returned 372.22% versus 13.36% for the benchmark. Overall, the current technical stance is mildly bullish, driven by the bullish MACD and KST, despite some bearish signals from the RSI and Dow Theory...."
      },
      {
        "title": "ATAI Life Sciences NV Hits New 52-Week High of $5.96",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/atai-life-sciences-nv-hits-new-52-week-high-of-596-3571372",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/ATAILifeScience_priceRelatedfactors_3571372.png",
        "date": "2025-09-25 16:52:29",
        "description": "ATAI Life Sciences NV achieved a new 52-week high of USD 5.96 on September 24, 2025, reflecting a significant year-over-year gain. The company, with a market capitalization of USD 969 million, remains unprofitable and has a high price-to-book ratio, indicating a premium valuation."
      },
      {
        "title": "ATAI Life Sciences NV Hits New 52-Week High of $5.76",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/atai-life-sciences-nv-hits-new-52-week-high-of-576-3565372",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/ATAILifeScience_priceRelatedfactors_3565372.png",
        "date": "2025-09-24 13:42:15",
        "description": "ATAI Life Sciences NV achieved a new 52-week high of USD 5.76 on September 23, 2025, reflecting a significant increase in stock performance over the past year. With a market capitalization of USD 969 million, the company operates in the competitive Pharmaceuticals & Biotechnology sector, focusing on growth despite financial challenges."
      },
      {
        "title": "ATAI Life Sciences Hits Day High with 14.96% Surge in Stock Price",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/atai-life-sciences-hits-day-high-with-1496-surge-in-stock-price-3565172",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/ATAILifeScience_priceRelatedfactors_3565172.png",
        "date": "2025-09-24 13:11:23",
        "description": "ATAI Life Sciences NV has seen significant stock activity, with notable gains over various time frames, including a remarkable increase over the past month. However, the company faces challenges, including a negative return on equity and ongoing losses, as it operates in a competitive Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Is ATAI Life Sciences NV technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-atai-life-sciences-nv-technically-bullish-or-bearish-3548335",
        "imagepath": "",
        "date": "2025-09-20 20:15:11",
        "description": "As of 11 September 2025, the technical trend for ATAI Life Sciences NV has changed from mildly bullish to bullish. The current stance is bullish with strong indicators supporting this view, particularly in the daily moving averages and weekly KST. However, the weekly and monthly RSI readings are bearish, indicating some weakness in momentum. The Bollinger Bands are bullish across both weekly and monthly time frames, suggesting price strength. \n\nIn terms of performance, ATAI has significantly outperformed the S&P 500, with a year-to-date return of 254.89% compared to the S&P's 12.22%, and a one-year return of 280.65% versus 17.14%. Overall, while there are mixed signals in some indicators, the prevailing trend is bullish...."
      },
      {
        "title": "Is ATAI Life Sciences NV overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-atai-life-sciences-nv-overvalued-or-undervalued-3544397",
        "imagepath": "",
        "date": "2025-09-20 18:45:12",
        "description": "As of 14 May 2025, ATAI Life Sciences NV has moved from a grade of does not qualify to risky. The company appears to be overvalued given its current financial metrics. The price-to-book value stands at 3.18, while the EV to EBITDA ratio is an alarming -4.41, and the return on capital employed (ROCE) is significantly negative at -130.41%. \n\nIn comparison to peers, such as Praxis Precision Medicines, Inc., which has a P/E ratio of -3.42 and an EV to EBITDA of -2.05, ATAI's valuation ratios indicate a concerning position within the industry. The stock has performed exceptionally well recently, with a year-to-date return of 254.89% compared to the S&P 500's 12.22%, suggesting strong market interest despite the underlying financial risks...."
      }
    ],
    "total": 12,
    "sid": "1289785",
    "stock_news_url": "https://www.marketsmojo.com/news/atai-life-sciences-nv-1289785"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is ATAI Life Sciences NV technically bullish or bearish?

2025-10-14 11:40:04

As of 10 October 2025, the technical trend for ATAI Life Sciences NV has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is also bullish, indicating positive momentum. However, the RSI shows a bearish stance on both the weekly and monthly charts, suggesting potential weakness. The Bollinger Bands are mildly bullish on both time frames, and the daily moving averages are bullish, supporting a positive short-term outlook. The KST is bullish on both weekly and monthly charts, but Dow Theory indicates a mildly bearish trend on the weekly, with no trend on the monthly. In terms of performance, ATAI Life Sciences has significantly outperformed the S&P 500 year-to-date with a return of 306.02% compared to the S&P 500's 11.41%. Over the past year, ATAI has returned 390.91%, while the S&P 500 returned 13.36%. Overall, the current technical stance is mildly bullish, driven b...

Is ATAI Life Sciences NV technically bullish or bearish?

2025-10-13 11:41:55

As of 10 October 2025, the technical trend for ATAI Life Sciences NV has changed from bullish to mildly bullish. The current stance is mildly bullish, driven by a bullish MACD on both weekly and monthly time frames, and bullish moving averages on the daily chart. However, the weekly and monthly RSI readings are bearish, indicating some weakness. Additionally, the Bollinger Bands are mildly bullish, while the Dow Theory shows a mildly bearish signal on the weekly chart. In terms of performance, ATAI Life Sciences has significantly outperformed the S&P 500 year-to-date with a return of 283.46% compared to the S&P 500's 11.41%, and over the past year, it has returned 372.22% versus the S&P 500's 13.36%....

Is ATAI Life Sciences NV technically bullish or bearish?

2025-10-12 11:29:01

As of 10 October 2025, the technical trend for ATAI Life Sciences NV has changed from bullish to mildly bullish. The weekly MACD and KST indicators remain bullish, while the daily moving averages are also bullish. However, the weekly and monthly RSI readings are bearish, indicating some weakness. The Bollinger Bands show a mildly bullish stance on both weekly and monthly time frames. According to Dow Theory, the weekly trend is mildly bearish, but there is no trend on the monthly level. In terms of performance, ATAI has significantly outperformed the S&P 500 year-to-date with a return of 283.46% compared to the S&P 500's 11.41%, and over the past year, it has returned 372.22% versus 13.36% for the benchmark. Overall, the current technical stance is mildly bullish, driven by the bullish MACD and KST, despite some bearish signals from the RSI and Dow Theory....

ATAI Life Sciences NV Hits New 52-Week High of $5.96

2025-09-25 16:52:29

ATAI Life Sciences NV achieved a new 52-week high of USD 5.96 on September 24, 2025, reflecting a significant year-over-year gain. The company, with a market capitalization of USD 969 million, remains unprofitable and has a high price-to-book ratio, indicating a premium valuation.

ATAI Life Sciences NV Hits New 52-Week High of $5.76

2025-09-24 13:42:15

ATAI Life Sciences NV achieved a new 52-week high of USD 5.76 on September 23, 2025, reflecting a significant increase in stock performance over the past year. With a market capitalization of USD 969 million, the company operates in the competitive Pharmaceuticals & Biotechnology sector, focusing on growth despite financial challenges.

ATAI Life Sciences Hits Day High with 14.96% Surge in Stock Price

2025-09-24 13:11:23

ATAI Life Sciences NV has seen significant stock activity, with notable gains over various time frames, including a remarkable increase over the past month. However, the company faces challenges, including a negative return on equity and ongoing losses, as it operates in a competitive Pharmaceuticals & Biotechnology sector.

Is ATAI Life Sciences NV technically bullish or bearish?

2025-09-20 20:15:11

As of 11 September 2025, the technical trend for ATAI Life Sciences NV has changed from mildly bullish to bullish. The current stance is bullish with strong indicators supporting this view, particularly in the daily moving averages and weekly KST. However, the weekly and monthly RSI readings are bearish, indicating some weakness in momentum. The Bollinger Bands are bullish across both weekly and monthly time frames, suggesting price strength. In terms of performance, ATAI has significantly outperformed the S&P 500, with a year-to-date return of 254.89% compared to the S&P's 12.22%, and a one-year return of 280.65% versus 17.14%. Overall, while there are mixed signals in some indicators, the prevailing trend is bullish....

Is ATAI Life Sciences NV overvalued or undervalued?

2025-09-20 18:45:12

As of 14 May 2025, ATAI Life Sciences NV has moved from a grade of does not qualify to risky. The company appears to be overvalued given its current financial metrics. The price-to-book value stands at 3.18, while the EV to EBITDA ratio is an alarming -4.41, and the return on capital employed (ROCE) is significantly negative at -130.41%. In comparison to peers, such as Praxis Precision Medicines, Inc., which has a P/E ratio of -3.42 and an EV to EBITDA of -2.05, ATAI's valuation ratios indicate a concerning position within the industry. The stock has performed exceptionally well recently, with a year-to-date return of 254.89% compared to the S&P 500's 12.22%, suggesting strong market interest despite the underlying financial risks....

View All News